In total, these results suggest that liver-specific deficiency of PLIN2 may act through distinct mechanisms to reduce hepatic TAG depending on the stage and severity of diet-induced NAFLD progression. Here, PLIN2 is linked to metabolic dysfunction-associated steatotic liver disease.